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Clinical manifestations
Bronchiolitis is a viral‐induced lower respiratory tract infection that 
occurs predominantly in children <2 years of age, particularly infants. 
Many viruses have been proven or attributed to cause bronchiolitis, 
including and most commonly the respiratory syncytial virus (RSV) 
and rhinovirus. Bronchiolitis may be diagnosed on the basis of 
clinical signs and symptoms. In a young child, the diagnosis can be 
made on the clinical pattern of wheezing and hyperinflation.
Clinical symptoms and signs typically start with an upper 
respiratory prodrome, including rhinorrhoea, low-grade fever, 
cough and poor feeding, followed 1 - 2 days later by tachypnoea, 
hyperinflation and wheeze as a consequence of airway inflammation 
and air trapping.[1] The illness is generally self limiting, but may 
progressively become more severe and include signs such as grunting, 
nasal flaring, subcostal chest wall retractions and hypoxaemia.[2] The 
most reliable clinical feature of bronchiolitis is hyperinflation of the 
chest, evident by loss of cardiac dullness on percussion, an upper 
border of the liver pushed down to below the 6th intercostal space, 
and the presence of a Hoover sign (subcostal recession, which occurs 
when a flattened diaphragm pulls laterally against the lower chest 
wall). 
Measurement of peripheral arterial oxygen saturation is useful to 
indicate the need for supplemental oxygen. A saturation of <92% at 
sea level and 90% inland indicates that the child requires hospital 
admission for supplemental oxygen.
Investigations
Chest radiographs
Chest radiographs (CXRs) are generally unhelpful and not required 
in children with a clear clinical diagnosis of bronchiolitis. 
Risk of airspace disease appears to be particularly low in children 
with saturation >92% and with mild to moderate distress.[3] A 
temperature ≥38°C has been shown to be a clinical predictor of 
radiographic abnormalities.[4] 
CXRs in bronchiolitis show signs of hyperinflation, peribronchial 
thickening or patchy areas of consolidation and collapse, which may 
be confused with signs of pneumonia. A CXR should only be done in 
the following instances:[2,4,5]
• if complications are suspected, e.g. pleural effusion or pneumo-
thorax
• severe cases
• temperature ≥38°C 
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Bronchiolitis may be diagnosed on the basis of clinical signs and symptoms. In a young child, the diagnosis can be made on the clinical 
pattern of wheezing and hyperinflation.
Clinical symptoms and signs typically start with an upper respiratory prodrome, including rhinorrhoea, low-grade fever, cough and poor 
feeding, followed 1 - 2 days later by tachypnoea, hyperinflation and wheeze as a consequence of airway inflammation and air trapping.
The illness is generally self limiting, but may become more severe and include signs such as grunting, nasal flaring, subcostal chest wall 
retractions and hypoxaemia. The most reliable clinical feature of bronchiolitis is hyperinflation of the chest, evident by loss of cardiac 
dullness on percussion, an upper border of the liver pushed down to below the 6th intercostal space, and the presence of a Hoover sign 
(subcostal recession, which occurs when a flattened diaphragm pulls laterally against the lower chest wall). 
Measurement of peripheral arterial oxygen saturation is useful to indicate the need for supplemental oxygen. A saturation of <92% at 
sea level and 90% inland indicates that the child has to be admitted to hospital for supplemental oxygen. Chest radiographs are generally 
unhelpful and not required in children with a clear clinical diagnosis of bronchiolitis. 
Blood tests are not needed routinely. Complete blood count tests have not been shown to be useful in diagnosing bronchiolitis or guiding 
its therapy. Routine measurement of C-reactive protein does not aid in management and nasopharyngeal aspirates are not usually done. 
Viral testing adds little to routine management.
Risk factors in patients with severe bronchiolitis that require hospitalisation and may even cause death, include prematurity, congenital 
heart disease and congenital lung malformations. 
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• uncertain diagnosis 
• if the child fails to improve or if their 
condition deteriorates.
Haematology
Blood tests are not needed routinely. Com-
plete blood count tests have not been shown 
to be useful in diagnosing bronchiolitis or 
guiding its therapy.[2] Routine measurement 
of C-reactive protein does not aid in manage-
ment.[6]
If the infant appears severely ill, consider 
alternative diagnoses (bacterial co-infection 
and other causes of airway obstruction). 
Clinical signs of concern include pallor, 
lethargy, severe tachycardia, high tempera-
ture, hypotonia or seizures. In cases of 
serious sepsis investigations may include a 
CXR, blood culture, and urinary and cere-
brospinal fluid analysis.[5]
Nasopharyngeal aspirates
Nasopharyngeal aspirates (NPAs) are not 
usually taken and viral testing adds little to 
routine management,[7] but NPAs are needed 
to inform surveillance, measuring burden 
of disease and also in the following cases:[5,7] 
• neonates (<1 month)
• history of apnoea with illness
• bed management to allow cohorting of 
patients.
NPAs should be immersed in viral transport 
medium at 4 - 8°C and transported to an 
appropriate laboratory within 72 hours of 
collection. Specimens should be tested by 
multiplex real-time reverse-transcription poly-
merase chain reaction (rRT-PCR) assay for 
respiratory viruses. Comparative studies have 
shown that rRT-PCR assays are sub stantially 
more sensitive than conventional methods, 
such as viral culture and immuno fluorescence 
assays, for detecting respiratory viruses.[8]
Furthermore, multiplex rRT-PCR has a 
significant advantage, as it permits simul-
taneous amplification of several viruses in 
a single reaction, facilitating a cost-effective 
diagnosis.[8] 
Risk factors for severe 
disease
In infants and young children respiratory virus-
es have the propensity to produce more serious 
lower respiratory tract illnesses, bronchiolitis 
and pneumonia. Infants <1 year of age are at 
greatest risk of bronchiolitis, and the disease 
is more severe when risk factors are present 
(Table 1).[9-15]
Debate about the importance of respiratory 
syncytial virus infection as a cause of 
hospitalisation in late preterm infants has 
raged because of the cost of prophylactic 
therapy. Recent reports have suggested that 
these infants are at equal risk and require 
prophylaxis.[16,17] 
South African studies have revealed that 
the mean duration of symptoms following 
bronchiolitis was 12 days (95% confidence 
interval 11 - 14 days). After 21 and 28 days, 
18% and 9%, respectively, were still ill. 
Thirty-four percent of these children were 
seen by a physician during an unscheduled 
visit.[18] 
Finally, the respiratory viruses, especially 
RSV, may predispose to recurrent episodes 
of wheezing and possibly asthma.[19,20] 
Differential diagnosis
The differential diagnosis of respiratory 
symptoms is wide, but where hyperinflation 
and wheeze occur the conditions listed in 
Table 2 should be considered. 
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Table 2. Differential diagnosis of 
bronchiolitis
Acute symptoms
Bronchopneumonia
Pertussis
Foreign body
Myocarditis
Recurrent wheeze
Cystic fibrosis
Cardiac disease
HIV/tuberculosis
Table 1. Risk factors for severe 
bronchiolitis, requiring hospitalisation 
or causing mortality
Premature infants
Congenital heart disease
Congenital lung malformations
Chronic lung disease
Neuromuscular disease
Age <6 months
Male sex
Siblings living in the household
Daycare attendance
Exposure to tobacco smoke
Immune compromise (malignancy, 
primary immunodeficiency, HIV*)
*Risk greatest for pneumonia.
